MicroRNA expression profiles associated with development of drug resistance in Ehrlich ascites tumor cells

Molecular Pharmaceutics

Volumn 8, Issue 6, 2011, Pages 2055-2062

  Husted, Susanne ^a   Søkilde, Rolf ^b   Rask, Lene ^a   Cirera, Susanna ^a   Busk, Peter Kamp ^c   Eriksen, Jens ^a   Litman, Thomas ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Department of Biomarker Discovery ^*  (Denmark)

^c AALBORG UNIVERSITY   (Denmark)

Author keywords

drug resistance; Ehrlich ascites tumor cells; in vitro; in vivo; microarrays; microRNA; qRT PCR

Indexed keywords

CISPLATIN; DOXORUBICIN; GENE PRODUCT; LOCKED NUCLEIC ACID; MICRORNA; PROTEIN ZEB1; PROTEIN ZEB2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER RESISTANCE; DOWN REGULATION; EHRLICH ASCITES TUMOR CELL; GENE CLUSTER; GENE EXPRESSION PROFILING; GENOMIC INSTABILITY; MICROARRAY ANALYSIS; MOUSE; MULTIDRUG RESISTANCE; MULTIGENE FAMILY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, EHRLICH TUMOR; CELL LINE, TUMOR; CISPLATIN; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICRORNAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 82955240683     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp200255d     Document Type: Article

References (47)

1. Gillet, J. P.; Gottesman, M. M. Mechanisms of multidrug resistance in cancer Methods Mol. Biol. 2010, 596, 47-76
2. Fojo, T. Multiple paths to a drug resistance phenotype: mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and microRNAs Drug Resist. Updates 2007, 10 (1-2) 59-67 (Pubitemid 46656478)
3. Mocellin, S.; Pasquali, S.; Pilati, P. Oncomirs: from tumor biology to molecularly targeted anticancer strategies Mini-Rev. Med. Chem. 2009, 9 (1) 70-80
4. Koturbash, I.; Zemp, F. J.; Pogribny, I.; Kovalchuk, O. Small molecules with big effects: The role of the microRNAome in cancer and carcinogenesis Mutat. Res. 2011, 722 (2) 94-105
5. Kovalchuk, O.; Filkowski, J.; Meservy, J.; Ilnytskyy, Y.; Tryndyak, V. P.; Chekhun, V. F.; Pogribny, I. P. Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin Mol. Cancer Ther. 2008, 7 (7) 2152-2159
6. Blower, P. E.; Chung, J. H.; Verducci, J. S.; Lin, S.; Park, J. K.; Dai, Z.; Liu, C. G.; Schmittgen, T. D.; Reinhold, W. C.; Croce, C. M.; Weinstein, J. N.; Sadee, W. MicroRNAs modulate the chemosensitivity of tumor cells Mol. Cancer Ther. 2008, 7 (1) 1-9
7. Dai, Y.; Xie, C. H.; Neis, J. P.; Fan, C. Y.; Vural, E.; Spring, P. M. MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance Head Neck 2011, 33 (6) 786-791
8. Persson, H.; Kvist, A.; Vallon-Christersson, J.; Medstrand, P.; Borg, A.; Rovira, C. The non-coding RNA of the multidrug resistance-linked vault particle encodes multiple regulatory small RNAs Nat. Cell Biol. 2009, 11 (10) 1268-1271
9. Chen, G. Q.; Zhao, Z. W.; Zhou, H. Y.; Liu, Y. J.; Yang, H. J. Systematic analysis of microRNA involved in resistance of the MCF-7 human breast cancer cell to doxorubicin Med. Oncol. 2010, 27 (2) 406-415
10. Litman, T.; Nielsen, D.; Skovsgaard, T.; Zeuthen, T.; Stein, W. D. ATPase activity of P-glycoprotein related to emergence of drug resistance in Ehrlich ascites tumor cell lines Biochim. Biophys. Acta 1997, 1361 (2) 147-158 (Pubitemid 27362088)
11. Litman, T.; Nielsen, D.; Skovsgaard, T.; Bukhave, K. Lipid composition of sensitive and multidrug resistant Ehrlich ascites tumor cells Cell. Pharm. 1995, 2, 9-14
12. Nielsen, D.; Maare, C.; Skovsgaard, T. Kinetics of daunorubicin transport in Ehrlich ascites tumor cells with different expression of P-glycoprotein Biochem. Pharmacol. 1994, 47 (12) 2125-2135
13. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J. T.; Bokesch, H.; Kenney, S.; Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening J. Natl. Cancer Inst. 1990, 82 (13) 1107-1112 (Pubitemid 20213250)
14. Søkilde, R.; Kaczkowski, B.; Barken, K. B.; Mouritzen, P.; Møller, S.; Litman, T. MicroRNA Expression Analysis by LNA Enhanced Microarrays. In MicroRNA profiling in cancer; World Scientific: Hackensack, NJ, 2009.
15. Balcells, I.; Cirera, S.; Busk, P. K. Specific and sensitive quantitative RT-PCR of miRNAs with DNA primers BMC Biotechnol. 2011, 11, 70
16. Maragkakis, M.; Reczko, M.; Simossis, V. A.; Alexiou, P.; Papadopoulos, G. L.; Dalamagas, T.; Giannopoulos, G.; Goumas, G.; Koukis, E.; Kourtis, K.; Vergoulis, T.; Koziris, N.; Sellis, T.; Tsanakas, P.; Hatzigeorgiou, A. G. DIANA-microT web server: elucidating microRNA functions through target prediction Nucleic Acids Res. 2009, 37 (Suppl. 2) W273-W276
17. Krek, A.; Grun, D.; Poy, M. N.; Wolf, R.; Rosenberg, L.; Epstein, E. J.; MacMenamin, P.; da Piedade, I.; Gunsalus, K. C.; Stoffel, M.; Rajewsky, N. Combinatorial microRNA target predictions Nat. Genet. 2005, 37 (5) 495-500 (Pubitemid 40617277)
18. Lewis, B. P.; Burge, C. B.; Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Cell 2005, 120, 15-20 (Pubitemid 40094598)
19. Litman, T.; Druley, T. E.; Stein, W. D.; Bates, S. E. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance Cell. Mol. Life Sci. 2001, 58 (7) 931-959 (Pubitemid 32652819)
20. Castoldi, M.; Benes, V.; Hentze, M. W.; Muckenthaler, M. U. miChip: a microarray platform for expression profiling of microRNAs based on locked nucleic acid (LNA) oligonucleotide capture probes Methods 2007, 43 (2) 146-152 (Pubitemid 47419363)
21. Chen, H.; Qian, K.; Tang, Z. P.; Xing, B.; Chen, H.; Liu, N.; Huang, X.; Zhang., S. Bioinformatics and microarray analysis of microRNA expression profiles of murine embryonic stem cells, neural stem cells induced from ESCs and isolated from E8.5 mouse neural tube Neurol. Res. 2010, 32, 603-613
22. Harris, A. J.; Dial, S. L.; Casciano, D. A. Comparison of basal gene expression profiles and effects of hepatocarcinogens on gene expression in cultured primary human hepatocytes and HepG2 cells Mutat. Res. 2004, 549, 79-99 (Pubitemid 38553977)
23. Chan, S. Y.; Loscalzo, J. microRNA-210: A unique and pleiotropic hypoxamir Cell Cycle 2010, 9 (6) 1072-1083
24. Crosby, M. E.; Kulshreshtha, R.; Ivan, M.; Glazer, P. M. MicroRNA regulation of DNA repair gene expression in hypoxic stress Cancer Res. 2009, 69 (3) 1221-1229
25. Kulshreshtha, R.; Ferracin, M.; Wojcik, S. E.; Garzon, R.; Alder, H.; Agosto-Perez, F. J.; Davuluri, R.; Liu, C. G.; Croce, C. M.; Negrini, M.; Calin, G. A.; Ivan, M. A MicroRNA Signature of Hypoxia Mol. Cell. Biol. 2007, 27 (5) 1859-1867
26. Guimbellot, J. S.; Erickson, S. W.; Mehta, T.; Wen, H.; Page, G. P.; Sorscher, E. J.; Hong, J. S. Correlation of microRNA levels during hypoxia with predicted target mRNAs through genome-wide microarray analysis BMC Med. Genomics 2009, 2 (15) 1-17
27. Zhan, M.; Miller, C. P.; Papayannopoulou, T.; Stamatoyannopoulos, G.; Song, C. Z. MicroRNA expression dynamics during murine and human erythroid differentiation Exp. Hematol. 2007, 35 (7) 1015-1025 (Pubitemid 46921304)
28. Merkerova, M.; Belickova, M.; Bruchova, H. Differential expression of microRNAs in hematopoietic cell lineages Eur. J. Haematol. 2008, 81 (4) 304-310
29. Cutler, G.; Marshall, L. A.; Chin, N.; Baribault, H.; Kassner, P. D. Significant gene content variation characterizes the genomes of inbred mouse strains Genome Res. 2007, 17, 1743-1754 (Pubitemid 351359998)
30. Quinlan, A. R.; Clark, R. A.; Sokolova, S.; Leibowitz, M. L.; Zhang, Y.; Hurles, M. E.; Mell, J. C.; Hall, I. M. Genome-wide mapping and assembly of structural variant breakpoints in the mouse genome Genome Res. 2010, 20, 623-635
31. Hasholt, L.; Visfeldt, J.; Dano, K. Karyotypic profile alterations in Ehrlich ascites tumour cells during development of resistance to daunorubicine Acta Pathol. Microbiol. Scand., Sect. A 1971, 79, 665-675
32. Landgraf, P.; Rusu, M.; Sheridan, R.; Sewer, A.; Iovino, N.; Aravin, A.; Pfeffer, S.; Rice, A.; Kamphorst, A. O.; Landthaler, M.; Lin, C.; Socci, N. D.; Hermida, L.; Fulci, V.; Chiaretti, S.; Foa, R.; Schliwka, J.; Fuchs, U.; Novosel, A.; Muller, R. U.; Schermer, B.; Bissels, U.; Inman, J.; Phan, Q.; Chien, M.; Weir, D. B.; Choksi, R.; De Vita, G.; Frezzetti, D.; Trompeter, H. I.; Hornung, V.; Teng, G.; Hartmann, G.; Palkovits, M.; Di Lauro, R.; Wernet, P.; Macino, G.; Rogler, C. E.; Nagle, J. W.; Ju, J.; Papavasiliou, F. N.; Benzing, T.; Lichter, P.; Tam, W.; Brownstein, M. J.; Bosio, A.; Borkhardt, A.; Russo, J. J.; Sander, C.; Zavolan, M.; Tuschl, T. A mammalian microRNA expression atlas based on small RNA library sequencing Cell 2007, 129 (7) 1401-1414 (Pubitemid 46970709)
33. Gregory, P. A.; Bert, A. G.; Paterson, E. L.; Barry, S. C.; Tsykin, A.; Farshid, G.; Vadas, M. A.; Khew-Goodall, Y.; Goodall, G. J. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 Nat. Cell Biol. 2008, 10 (5) 593-601 (Pubitemid 351627379)
34. Yilmas, M.; Christofori, G. Mechanisms of motility in metastasizing cells Mol. Cancer Res. 2010, 8, 629-642
35. Green, S. K.; Francia, G.; Isidoro, C.; Kerbel, R. S. Antiadhesive antibodies targeting E-cadherin sensitize multicellular tumor spheroids to chemotherapy in vitro Mol. Cancer Ther. 2004, 3, 149-159 (Pubitemid 39193689)
36. Guttilla, I. K.; White, B. A. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells J. Biol. Chem. 2009, 284 (35) 23204-23216
37. Myatt, S. S.; Wang, J.; Monteiro, L. J.; Christian, M.; Ho, K. K.; Fusi, L.; Dina, R. E.; Brosens, J. J.; Ghaem-Maghami, S.; Lam, E. W. Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer Cancer Res. 2010, 70 (1) 367-377
38. Goto, T.; Takano, M. Transcriptional role of FOXO1 in drug resistance through antioxidant defense systems Adv. Exp. Med. Biol. 2009, 665, 171-179
39. Ritchie, W.; Flamant, S.; Rasko, J. E. Predicting microRNA targets and functions: traps for the unwary Nat. Methods. 2009, 6 (6) 397-398
40. Tsuchiya, S.; Fujiwara, T.; Sato, F.; Shimada, Y.; Tanaka, E.; Sakai, Y.; Shimizu, K.; Tsujimoto, G. MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1) J. Biol. Chem. 2011, 286 (1) 420-428
41. Jardin, F.; Callanan, M.; Penther, D.; Ruminy, P.; Troussard, X.; Kerckaert, J. P.; Figeac, M.; Parmentier, F.; Rainville, V.; Vaida, I.; Bertrand, P.; Duval, A. B.; Picquenot, J. M.; Chaperot, L.; Marolleau, J. P.; Plumas, J.; Tilly, H.; Bastard, C. Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease Leukemia 2009, 23 (4) 698-707
42. Gao, W.; Shen, H.; Liu, L.; Xu, J.; Xu, J.; Shu, Y. MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. J. Cancer Res Clin. Oncol. 2010.
43. Kumar, M.; Lu, Z.; Takwi, A. A.; Chen, W.; Callander, N. S.; Ramos, K. S.; Young, K. H.; Li, Y. Negative regulation of the tumor suppressor p53 gene by microRNAs Oncogene 2011, 30 (7) 843-853
44. Wang, K. C.; Garmire, L. X.; Young, A.; Nguyen, P.; Trinh, A.; Subramaniam, S.; Wang, N.; Shyy, J. Y.; Li, Y. S.; Chien, S. Role of microRNA-23b in flow-regulation of Rb phosphorylation and endothelial cell growth Proc. Natl. Acad. Sci. U.S.A. 2010, 107 (7) 3234-3239
45. Trumpp, A.; Essers, M.; Wilson, A. Awakening dormant haematopoietic stem cells Nat. Rev. Immunol. 2010, 10 (3) 201-209
46. Zhu, H.; Wu, H.; Liu, X.; Evans, B. R.; Medina, D. J.; Liu, C. G.; Yang, J. M. Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells Biochem. Pharmacol. 2008, 76 (5) 582-588
47. Li, Z.; Hu, S.; Wang, J.; Cai, J.; Xiao, L.; Yu, L.; Wang, Z. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells Gynecol. Oncol. 2010, 119 (1) 125-130